Justin M. Balko - Concepedia

Author

Justin M. Balko

Vanderbilt University Medical Center ORCID

Also Known As

Abramson, Vandana G., Adrian Lee, Balko, Justin, Balko, Justin M., Hicks, Donna, J Balko, J M Balko, J. Balko, J. M. Balko, J.M Balko

709

Publications

29.7K

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Medical Center Vanderbilt University Breast Cancer Research Foundation Dana-Farber Cancer Institute The University of Texas MD Anderson Cancer Center

About

Justin M. Balko is an author at Vanderbilt University Medical Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	42	9.2K
2	Engineering	4	4	776
3	Health Sciences	2	2	175
4	Natural Sciences	1	1	315
5	Allergy	1	1	64

Justin M. Balko

107

Publications

18.8K

Citations

H-Index

Page 1

	Year	Citations
Fulminant Myocarditis with Combination Immune Checkpoint Blockade Douglas B. Johnson, Justin M. Balko, Margaret Compton, New England Journal of Medicine Fatal MyocarditisCancer ImmunosurveillanceSkeletal MuscleMedicineFulminant Myocarditis	2016	2.2K
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data Francesca Finotello, Clemens Mayer, Christina Plattner, Genome Medicine	2019	1.6K
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study Joe‐Elie Salem, Ali Manouchehri, Melissa Moey, The Lancet Oncology InflammationCardiovascular ToxicityImmunotoxicologyCardiovascular DiseasePharmacovigilance Study	2018	1.1K
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer Rinath Jeselsohn, Roman Yelensky, Gilles Buchwalter, Clinical Cancer Research	2014	633
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy Daniel Shae, Kyle W. Becker, Plamen P. Christov, Nature Nanotechnology Polymer-drug ConjugateCyclic Dinucleotide StingImmunologyOligonucleotideMolecular Biology	2019	633
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation Kyung‐min Lee, Jennifer M. Giltnane, Justin M. Balko, Cell Metabolism Tumor BiologyBreast OncologyMitochondrial FunctionMedicineMitochondrial Oxidative Phosphorylation	2017	625
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer Neil E. Bhola, Justin M. Balko, Teresa C. Dugger, Journal of Clinical Investigation	2013	586
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy Douglas B. Johnson, Mónica V. Estrada, Roberto Salgado, Nature Communications ImmunologyImmunologic MechanismMelanoma-specific Mhc-ii ExpressionImmunotherapyTumor Biology	2016	558
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors Sherene Loi, Sathana Dushyanthen, Paul A. Beavis, Clinical Cancer Research	2015	546
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade Douglas B. Johnson, Garrett M. Frampton, Matthew J. Rioth, Cancer Immunology Research EngineeringPd-1 BlockadeImmunologyImmunotherapyMolecular Diagnostics	2016	486

Page 1